Conflicts of Interest in Healthcare: The $12 Billion Truth
By Wade Emmert
Every year, drug and device manufacturers spend between $12 and $15 billion on financial relationships with healthcare providers.
Is it just "lunch," or is it buying influence?
In this episode, Wade sits down with Aaron Narva, Founder and CEO of Conflixis, to uncover the reality of conflicts of interest in the healthcare industry. They move beyond the "compliance checklist" to look at the hard data found in Open Payments.
Aaron reveals that 70% of reportable relationships go undisclosed to hospital systems and breaks down the staggering ROI of industry payments - where $1 spent on a provider often correlates to $7 in increased spending the following year.
In this episode, we cover:
(00:00:00) Introduction to Aaron
(00:03:00) The Gap: Why hospital COI policies fail to capture reality.
(00:09:40) The $12 Billion Economy: Understanding the Open Payments database.
(00:19:00) The "Ozempic" Effect: Data correlating payments to prescription volume.
(00:27:00) The ROI of Influence: How industry turns $1 into $7.
(00:33:00) Physician Advice: Why you must check (and correct) your Open Payments data.
(00:37:00) Risk Management: Moving from "form collection" to data intelligence.
By Wade Emmert
Every year, drug and device manufacturers spend between $12 and $15 billion on financial relationships with healthcare providers.
Is it just "lunch," or is it buying influence?
In this episode, Wade sits down with Aaron Narva, Founder and CEO of Conflixis, to uncover the reality of conflicts of interest in the healthcare industry. They move beyond the "compliance checklist" to look at the hard data found in Open Payments.
Aaron reveals that 70% of reportable relationships go undisclosed to hospital systems and breaks down the staggering ROI of industry payments - where $1 spent on a provider often correlates to $7 in increased spending the following year.
In this episode, we cover:
(00:00:00) Introduction to Aaron
(00:03:00) The Gap: Why hospital COI policies fail to capture reality.
(00:09:40) The $12 Billion Economy: Understanding the Open Payments database.
(00:19:00) The "Ozempic" Effect: Data correlating payments to prescription volume.
(00:27:00) The ROI of Influence: How industry turns $1 into $7.
(00:33:00) Physician Advice: Why you must check (and correct) your Open Payments data.
(00:37:00) Risk Management: Moving from "form collection" to data intelligence.